Jensen RA - Search Results

1

p53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment.

Caleffi M, Teague MW, Jensen RA, Vnencak-Jones CL, Dupont WD, Parl FF. Caleffi M, et al. Among authors: jensen ra. Cancer. 1994 Apr 15;73(8):2147-56. doi: 10.1002/1097-0142(19940415)73:8<2147::aid-cncr2820730820>3.0.co;2-5. Cancer. 1994. PMID: 8156519

2

Excellent survival, cancer type, and Nottingham grade after atypical lobular hyperplasia on initial breast biopsy.

McLaren BK, Schuyler PA, Sanders ME, Jensen RA, Simpson JF, Dupont WD, Page DL. McLaren BK, et al. Among authors: jensen ra. Cancer. 2006 Sep 15;107(6):1227-33. doi: 10.1002/cncr.22113. Cancer. 2006. PMID: 16894523 Free article.

3

Invasive breast cancer risk in women with sclerosing adenosis.

Jensen RA, Page DL, Dupont WD, Rogers LW. Jensen RA, et al. Cancer. 1989 Nov 15;64(10):1977-83. doi: 10.1002/1097-0142(19891115)64:10<1977::aid-cncr2820641002>3.0.co;2-n. Cancer. 1989. PMID: 2804888

4

Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy.

Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA. Page DL, et al. Among authors: jensen ra. Cancer. 1995 Oct 1;76(7):1197-200. doi: 10.1002/1097-0142(19951001)76:7<1197::aid-cncr2820760715>3.0.co;2-0. Cancer. 1995. PMID: 8630897

5

Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma.

Page DL, Salhany KE, Jensen RA, Dupont WD. Page DL, et al. Among authors: jensen ra. Cancer. 1996 Jul 15;78(2):258-66. doi: 10.1002/(SICI)1097-0142(19960715)78:2<258::AID-CNCR11>3.0.CO;2-V. Cancer. 1996. PMID: 8674001

6

Papillary apocrine change of the breast: associations with atypical hyperplasia and risk of breast cancer.

Page DL, Dupont WD, Jensen RA. Page DL, et al. Among authors: jensen ra. Cancer Epidemiol Biomarkers Prev. 1996 Jan;5(1):29-32. Cancer Epidemiol Biomarkers Prev. 1996. PMID: 8770463

7

Monoclonality in fibroadenomas with complex histology and phyllodal features.

Kasami M, Vnencak-Jones CL, Manning S, Dupont WD, Jensen RA, Page DL. Kasami M, et al. Among authors: jensen ra. Breast Cancer Res Treat. 1998 Jul;50(2):185-91. doi: 10.1023/a:1006050208157. Breast Cancer Res Treat. 1998. PMID: 9822223

8

Estrogen replacement therapy in women with a history of proliferative breast disease.

Dupont WD, Page DL, Parl FF, Plummer WD Jr, Schuyler PA, Kasami M, Jensen RA. Dupont WD, et al. Among authors: jensen ra. Cancer. 1999 Mar 15;85(6):1277-83. doi: 10.1002/(sici)1097-0142(19990315)85:6<1277::aid-cncr9>3.0.co;2-e. Cancer. 1999. PMID: 10189132

9

Diagnostic criteria and cancer risk of proliferative breast lesions.

Jensen RA, Dupont WD, Page DL. Jensen RA, et al. J Cell Biochem Suppl. 1993;17G:59-64. doi: 10.1002/jcb.240531111. J Cell Biochem Suppl. 1993. PMID: 8007711 Review.

10

Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas.

Gobbi H, Arteaga CL, Jensen RA, Simpson JF, Dupont WD, Olson SJ, Schuyler PA, Plummer WD Jr, Page DL. Gobbi H, et al. Among authors: jensen ra. Histopathology. 2000 Feb;36(2):168-77. doi: 10.1046/j.1365-2559.2000.00841.x. Histopathology. 2000. PMID: 10672063

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

490 results

Search Page

Filters